Protein C News and Research

RSS
Study finds that Omicron variant preferentially uses the endosome pathway through mutation in the spike protein

Study finds that Omicron variant preferentially uses the endosome pathway through mutation in the spike protein

Study evaluates mutation-induced SARS-CoV-2 spike protein fold stability

Study evaluates mutation-induced SARS-CoV-2 spike protein fold stability

Study finds fractionation of sulfated galactan from red alga can isolate its anti-SARS-CoV-2 properties

Study finds fractionation of sulfated galactan from red alga can isolate its anti-SARS-CoV-2 properties

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Sino Biological and Ainnocence Partner to Offer Next-Generation Antibody Development CRO Services

Sino Biological and Ainnocence Partner to Offer Next-Generation Antibody Development CRO Services

Non-hormonal male contraceptive effectively prevents pregnancy in mice

Non-hormonal male contraceptive effectively prevents pregnancy in mice

Mineralocorticoid receptor antagonist use linked to improved renal prognosis in CKD patients

Mineralocorticoid receptor antagonist use linked to improved renal prognosis in CKD patients

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

New therapy makes immunologically 'cold' tumors hot enough for immune attack

New therapy makes immunologically 'cold' tumors hot enough for immune attack

Scientists develop first drug to treat uncontrolled secretion of mucins in the airways

Scientists develop first drug to treat uncontrolled secretion of mucins in the airways

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

FDA approves new treatment for patients with metastatic melanoma based on Johns Hopkins research

FDA approves new treatment for patients with metastatic melanoma based on Johns Hopkins research

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

UI neuroscientists identify fundamental biochemical mechanism underlying memory storage

UI neuroscientists identify fundamental biochemical mechanism underlying memory storage

TTUHSC researcher secures $1.9 million grant to investigate vulnerabilities in ALT cancers

TTUHSC researcher secures $1.9 million grant to investigate vulnerabilities in ALT cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.